By Colin Kellaher
Shares of Sionna Therapeutics are set to be traded Friday after the clinical-stage biopharmaceutical company's upsized initial public offering was priced at the top end of expectations.
Sionna late Thursday said it is selling nearly 10.6 million shares at $18 apiece in the IPO, compared with prior plans to offer about 8.82 million shares at between $16 and $18 each.
The Waltham, Mass., company said it expects gross proceeds of about $191 million.
Sionna shares are slated to begin trading Friday on the Nasdaq Global Market under the symbol SION.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
February 07, 2025 06:18 ET (11:18 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.